Nedbank Private Wealth Investment Research rates Advanced Health a share to hold. An Investment Team member outlines the opportunities, challenges and risks the company faces. Click here for the full report.
The Day Hospital Association testified at the Competition Commission inquiry into private-hospital costs on 8 March 2016. Represented by Advanced CEO Carl Grillenberger and Cure managing director Bert von Wiellligh, the association highlighted the effect of market dominance and licensing procedures on private hospital inflation, which impact negatively on the private hospital industry. Day hospitals [...]